Open | - |
Close | - |
Volume / Avg. | 5.013K / 211.778K |
Day Range | - - - |
52 Wk Range | 1.150 - 3.870 |
Market Cap | $51.719M |
P/E Ratio | 0.963 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | % |
Days to Cover | 9.64 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of SCYNEXIS (NASDAQ: SCYX) through any online brokerage.
Other companies in SCYNEXIS’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP) and Rani Therapeutics Hldgs (NASDAQ:RANI).
The latest price target for SCYNEXIS (NASDAQ: SCYX) was reported by Cantor Fitzgerald on Tuesday, August 15, 2023. The analyst firm set a price target for 15.00 expecting SCYX to rise to within 12 months (a possible 979.14% upside). 3 analyst firms have reported ratings in the last year.
The stock price for SCYNEXIS (NASDAQ: SCYX) is $1.39 last updated Today at March 19, 2024 at 9:30 AM EDT.
There are no upcoming dividends for SCYNEXIS.
SCYNEXIS’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for SCYNEXIS.
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.